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Abstract: Two new chloro-furanocembranolides (1, 2) and two new 1,4-diketo cembranolides (3, 4)
were isolated from the crude extract of Leptogorgia sp. together with a new seco-furanocembranolide
(5) and the known Z-deoxypukalide (6), rubifolide (7), scabrolide D (8) and epoxylophodione (9).
Their structures were determined based on spectroscopic evidence. Four compounds: 1, 2, 7 and 8
were found to activate the proliferation of pancreatic insulin-producing (beta) cells.
Keywords: Leptogorgia; cembranolides; furanocembranolides; diketocembranolides;
seco-furanocembranolides; chloro-furanocembranolides; pancreatic beta-cells
1. Introduction
Octocorals of the genus Leptogorgia biosynthesize highly oxygenated diterpenoids based
on the cembrane skeleton: (a) furanocembranolides into which a γ-lactone subunit is
embedded; (b) 1,4-diketocembranoids produced by oxidative cleavage of the furan ring; and (c)
nor-1,4-diketocembranolides that lack the C-18 isoprenic methyl group [1,2].
It has been suggested that activation of pancreatic beta-cell proliferation is a strategy to
maintain functional beta-cell mass in diabetes mellitus [3]. Regarding this, we have shown that
furanocembranoids such as epoxypukalide, pukalide, Z-deoxypukalide and leptolide improve
beta-cell proliferation [4–6]. This prompted us to study a new extract of Leptogorgia sp. collected
by SCUBA diving off Aleta (Panama), from which compounds 1–9 were obtained after flash
chromatography followed by HPLC (Figure 1). The unusual halogenated compounds 1 and 2, together
with the known Z-desoxypukalide (6) [1] and rubifolide (7) [7] belong to the furanocembranolide
structural class. The remaining six compounds typify three different subclasses that involve several
types of rearrangements from a furanocembranolide precursor: (a) 3, 4 and the previously isolated
epoxylophodione (9) [8] are 1,4-diketocembranolides, 4 being the only haloderivative of the genus
Leptogorgia of this subclass; (b) compound 5 is the first seco-furanocembranolide isolated from genus
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Leptogorgia, which showed a similar ring scission pattern to seco-bipinnatin J, the only seco-derivative [9]
isolated from Pseudopterogorgia; and (c) scabrolide D (8) [10] is a nor-1,4-diketocembranolide which
lacks the C-18 isoprenic methyl group.
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Figure 1. Novel chloro-furanocembranolides (1, 2), 1,4-diketocembranolides (3, 4), seco-furanocembranolide
(5) and the known Z-deoxypukalide (6), rubifolide (7), scabrolide D (8) and epoxylophodione (9) from
Leptogorgia sp.
2. Results
Compound 1 wa obtained as an oil whose EIMS spectrum showed peaks at /z [M − 1]+
409/411, with relative intensities suggesting one chlorine atom. These peaks correspond to the
molecular formula C20H23ClO7 (HREIMS) (m/z 409.1041 [M − 1]+, calcd. for C20H2235ClO7 409.1054).
The diterpenic nature of 1 is corroborated by the 13C NMR spectrum (in Supplementary Materials),
which displayed correlations in the HSQC spectrum indicative of seven quaternary carbons, six
methines, six methylenes and one methyl (Table 1). Absorptions for a hydroxyl group at 3476 cm−1
and carbonyl groups at 1776 and 1676 cm−1 were observed in the IR spectrum.
Notable 1H and 13C NMR signals are: an aldehyde group [δH-18 9.89 (1H, s), δC-18 184.7],
a trisubstituted furane ring [δH-5 6.70 (1H, s), δC-5 10 .5; δC-3 161.3; δC-6 156.0; δC-4 123.4],
a α,β-epoxy-γ-lactone ring [δH-11 3.73 (1H, s), δC-11 62.9; δC-20 172.1; δH-10 4.85 (1H, dd, J = 5.2, 11.3 Hz),
δC-10 74.3 and δC-12 60.6] and a chl romethylene [δH-17 4.18 (2H, br s) y δC-17 46.6].
Connectivity information obtained from COSY, HSQC and HMBC experiments unambiguously
determined the planar structure of compound 1 as a furanocembranolide, containing a C-18 oxidized to
aldehyde, a vicinal diol at C-7–C-8, a C-10–C-20 α,β-epoxy-γ-lactone moiety and a chloroisopropenyl
group at C-1.
Mar. Drugs 2018, 16, 49 3 of 11
1H-1H-COSY experiments established two spin systems: H2-2–H2-13 (fragment I) and H2-9–H-10
(fragment II) (Figure 2). The HMBC correlations H2-16/C-17, C-15, C-1 and H2-17/C-16, C-15, C-1
locate a chloroisopropenyl group at C-1 of fragment I, whereas the correlations H3-19/C-7, C-8 and C-9
allowed us lengthen fragment II by adding a vicinal dihydroxyl moiety bonded to C-9. The north end
of both fragments II and I are connected together by insertion of a furane ring, in agreement with the
HMBC correlations H-5/C-3, C-4, C-6 and H2-2 with C-4. An epoxy lactone binds the southern ends
of fragments I and II between C-13 and C-10, as deduced from the HMBC correlations H-10/C-11,
C-12, C-20; H2-13/C-20, C-11, C-12 and H2-14 with C-12. Thus, the structure of 1, with nine degrees of
unsaturation, has been established.
Table 1. 1H and 13C NMR spectroscopic data [500 and 125 MHz, CDCl3] of compounds 1 and 2.
No.
1 2
δC, Type δH (J in Hz) δC, Type δH (J in Hz)
1 37.6, CH 3.39, m 39.7, CH 2.46, dddd (2.2, 2.5, 9.5, 11.7)
2 32.9, CH2 3.15, m 32.7, CH2
a: 2.97, dd (2.5, 14.8)
b: 3.19, dd (11.9, 15.1)
3 161.3, C - 162.1, C -
4 123.4, C - 122.7, C -
5 106.5, CH 6.70, s 106.5, CH 6.80, s
6 156.0, C - 154.3, C -
7 74.0, CH 5.29, s 75.6, CH 4.59, s
8 74.3, C - 73.6, C -
9 40.5, CH2
1.51, m
1.87, dd (5.2, 15.0) 43.0, CH
b: 1.89, dd (11.7, 14.8)
a: 2.59, dd (4.2, 14.8)
10 74.3, CH 4.85, dd (5.2, 11.3) 78.4, CH 4.97, m
11 62.9, CH 3.73, s 148.6, C 5.86, s
12 60.6, C - 136.2, C -
13 22.5, CH2
a: 1.45, m
b: 2.44, dd (11.5, 14.7) 21.7, CH2
a: 2.14, m
b: 2.35, ddd (2.8, 11.9, 15.1)
14 30.4, CH2
1.42, m
2.04, m 30.2, CH2
1.60, ddd (2.8, 2.8, 15.1)
2.02, m








17 46.6, CH2 4.18, br s 47.2, CH2 4.12, br s
18 184.7, CH 9.89, s 184.3, CH 9.97, s
19 22.4, CH3 1.35, s 19.6, CH3 1.41, s
20 172.1, C - 173.5, C -
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Compound 2 was obtained as an oil whose EIMS spectrum showed a molecular ion at m/z [M]+
394/396, with an isotopic pattern for a chlorine atom in the molecular formula C20H23ClO6 (HREIMS)
(m/z 394.1181 [M]+, calcd. for C20H2335ClO6 394.1183). The 13C NMR spectrum and correlations in the
HSQC spectrum indicated seven quaternary carbons, six methines, six methylenes and one methyl
(Table 1). Absorptions for a hydroxyl group at 3558 cm−1 and carbonyl group at 1747 cm−1 were
observed in its IR spectrum.
1H and 13C NMR data resemble those of 1. The principal differences lie in the chemical shifts
of H-7, H2-9, C-9 and C-19, which were: δH-7 4.59 (1H, s), δH-9 1.89 (1H, m); 2.59 (1H, dd); δC-9 43.0
and δC-19 19.6, compared with those of 1 (Table 1). These shift values suggested that compounds 1
and 2 differ in the configuration of C-7 and C-8. Also, their molecular formulas diverge by 16 amu of
oxygen. This suggests that the γ-lactone ring system is devoid of the epoxide ring on 2. This absence
is confirmed by the new signals observed in the 1H and 13C NMR spectra for a proton (δH-11 5.86
(1H, s)) of a disubstituted olefin (δC-11 148.6; δC-12 136.2). Thus, the structure of 2 with nine degrees of
unsaturation was established as shown in Figure 1 by COSY, HSQC and HMBC experiments.
The relative configurations of compounds 1 and 2 were ascertained by NOESY experiments,
molecular mechanics [11], chemical shift studies and comparison of their spectroscopic data with those
of previously described cembranoids, leptodiol [1], lophodiol A [12] and sinumaximol B [13] (Figure 3).
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which are very similar to those presented by compound 2 in comparison to compound 1. 
Figure 3. Selected NOE effects (↔) of 1 and 2 and leptodiol, lophodiol A and sinumaximol B.
In compound 1, the observed NOEs of H-5 with H-7 and H3-19, together with those of H-7
with H3-19 suggested that the adjacent hydroxyl groups at C-7–C-8 should be in a cis relationship.
In compound 2, the observed NOEs of H3-19 with H-5 and H-10 indicate that these protons and Me-19
must be on same side of the molecule, whereas the NOEs of H3-19 with H-9a and of H-7 with H-9b
indicates that H-7 and Me-19, so the vicinal diols on C-7–C-8, have a trans-relationship. Therefore, the
relative configuration of C-8 is opposite to that on compound 1.
The configurations of C-7–C-8 vicinal diols were corroborated by comparison of the 1H and 13C
NMR chemical shifts around the diol moiety C-7–C-8 of compounds 1 and 2 with those of the related
diols leptodiol, lophodiol A and sinumaximol B, shown in Table 2. The chemical shifts of C-19 and H-7
of compounds 1 and 2 present strong differences (∆δC-19 = 2.8 ppm and ∆δH-7 = 0.7). The chemical
shifts of C-19 and H-7 of leptodiol (δC-19 22.7; δH-7 5.12) and lophodiol A (δC-19 22.7; δH-7 5.24), both
with the C-7–C-8 diols in an α-cis-relationship, are very similar to those of compound 1. Whereas the
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chemical shifts of C-19 and H-7 of sinumaximol B (δC-19 19.8; δH-7 4.52), whose C-7–C-8 diols show a
trans-relationship, present strong differences (upfield ∆δC-19 ≈ 2.6 ppm and downfield ∆δH-7 ≈ 0.8)
which are very similar to those presented by compound 2 in comparison to compound 1.
In compound 1, a striking 1H NMR signal is the singlet observed for H-11 (δ 3.73, s) due to the
roughly 90◦ dihedral angle formed between H-10 and H-11. This results in a small JH-10, H-11 that
confirms the relative configuration of C-10 and C-11 as represented in the energetically favourable
conformation shown in Figure 3.
Finally, in compound 1, the relative configuration of C-1 was secured by the NOESY correlation
of H-13b with H-1 and H-13a with H-11, as shown in the 3D model in Figure 3. In compound 2,
the observed NOEs of H-1 with H-2a and H-14a, as well as of H-14a with H-11 and of H-2b with H-14b,
indicate that the isopropenyl group of 2 is situated on the alpha side of the molecule. Therefore, both
compounds belong to the furanocembranolide of the α-series and their relative configurations are: 1R*,
7S*, 8S*, 10S*, 11S* and 12S* for compound 1 and 1R*, 7S*, 8R* and 10S* for compound 2.
Table 2. Selected 1H and 13C NMR data [CDCl3] of leptodiol, lophodiol A, 1, sinumaximol B and 2.
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Compound 3 was obtained as an oil whose EIMS spectrum showed a peak at m/z 362 [M]+, which 
corresponds to the molecular formula C20H26O6 (HREIMS) (m/z 362.1737 [M]+, calcd. for C20H26O6 
362.1729). These data are in agreement with the 13C NMR spectrum, which displayed correlations in 
the HSQC spectrum indicative of seven quaternary carbons, four methines, six methylenes and three 
methyls. Absorptions for a hydroxyl group at 3475 cm−1 and carbonyl groups at 1751, 1721 and 1701 
cm-1 were observed in their IR spectrum. According to the degree of unsaturation given by the 13C 
NMR data, 3 must be a tricyclic compound. 
In the 1H and 13C NMR experiments (Table 3), signals were found for: α,β-unsaturated-γ-lactone 
ring [δH-11 6.76 (1H, s), δC-11 155.9; δC-20 170.6; δC-10 90.5]; isopropenyl group [δH-16 4.68 (1H, br s), δH-16 
4.70 (1H, br s); δC-16 109.7] and [δH-17 1.69 (3H, s); δC-17 20.9]; methyl group on a quaternary carbon 
bonded to oxygen [δH-19 1.37 (CH3, s) and δC-8 74.3]; oximethine proton bonded to a secondary carbon 
[δH-5 3.31 (1H, d, 10.4 Hz) and δC-5 60.8] and two carbonyls [δC-3 215.4 and δC-6 203.5]. 
1H-1H-COSY experiments established two spin systems: H2-2–H2-13 (fragment I) and H3-18–H-
5 (fragment II) (Figure 4). The HMBC correlations of H2-16/C-1, C-17 and H3-17/C-16, C-15, C-1 locates 
the isopropenyl group at C-1 in fragment I, whereas the HMBC correlations of H2-2 and H3-18 with 
C-3 connects fragments I and II through C-3. The HMBC correlations H3-19/ C-7, C-8, C-9, along with 
those of H-5 and H2-7 with C-6, allowed us to extend fragment II by connecting it with substructure 
III through C-6. Both ends of the fragment I and substructure III (C-6–C-9) are connected by inserting 
an α,β-unsaturated γ-lactone bonded to C-13 and C-9, respectively, due to the HMBC correlations 
H2-13/C-20, C-11, C-12 and those of H-11/C-10 and H2-9/C-10, C-11. The quaternary feature of C-10 
comes from the oxygen linkage between C-5 and C-10 supported by an HMBC correlation of H-5 
with C-10. Therefore, the tricyclic structure of 3 has been established as depicted in Figure 4. 
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No. Leptodiol Lophodiol A 1 Sinumaximol B 2
δH-7 5 12, br s 5.24, s 5.29, s 4.52, s 4 59, s
δH-9
1.61, dd (8.8, . )
1.68, dd (6.9, 14.5)
1.55, m
1.76, dd (6. , 14.8)
1.55, m
1.76, dd (6.4, 14.8)
1.85, d (11.5, )
2.55, dd (4.0, 14.5)
1.89, 1.7, 14.8)
2.59, dd (4.2, 14.8)
δH-19 1.38, s 1.40 s 1.40, s 1.38, s 1.41, s
δC-19 22.7 22.7 22.4 19.8 19.6
δC-7 73.5 73.4 74.0 76.1 75.6
δC-9 41.1 40.9 40.5 43.2 43.0
Compound 3 was obtained as an oil whose EIMS spectrum showed a peak at m/z 362 [M]+, which
corresponds to the molecular formula C20H26O6 (HREIMS) (m/z 362.1737 [M]+, calcd. for C20H26O6
362.1729). These data are in agreement with the 13C NMR spectrum, which displayed correlations
in the HSQC spectrum indicative of seven quaternary carbons, four methines, six methylenes and
three methyls. Absorptions for a hydroxyl group at 3475 cm−1 and carbonyl groups at 1751, 1721 and
1701 cm−1 were observed in their IR spectrum. According to the degree of unsaturation given by the
13C NMR data, 3 must be a tricyclic compound.
In the 1H and 13C NMR experiments (Table 3), signals were found for: α,β-unsaturated-γ-lactone
ring [δH-11 6.76 (1H, s), δC-11 155.9; δC-20 170.6; δC-10 90.5]; isopr penyl group [δH-16 4.68 (1H, br s),
δH-16 4.70 (1 , br s); δC-16 109.7] and [δH-17 1.69 (3H, s); -17 20.9]; methyl group on a quaternary
carbon bonded to oxygen [δH-19 1.37 (CH3, s) and δC-8 74.3]; oximethine p oton bonded to a secondary
carbon [δH-5 3.31 (1H, d, 10 4 z) and δC-5 60.8] and two carbonyls [δC-3 215.4 and δC-6 203.5].
1H-1H-COSY experiments est blished o spin systems: H2-2–H2-13 (fragment I) and H3-18–H-5
(fragment II) (Figure 4). The HMBC c rrelations of 2-16/C-1, C-17 and H3-17/C-16, C-15, C-1 locates
the isopropenyl group at C-1 in fragment I, whereas the HMBC correlations of H2-2 and H3-18 with
C-3 connects fragments I and II through C-3. The HMBC correlations H3-19/ C-7, C-8, C-9, along with
those of H-5 and H2-7 with C-6, allowed us to extend fragment II by connecting it with substructure
III through C-6. Both ends of the fragment I and substructure III (C-6–C-9) are connected by inserting
an α,β-unsaturated γ-lactone bonded to C-13 and C-9, respectively, due to the HMBC correlations
H2-13/C-20, C-11, C-12 and those of H-11/C-10 and H2-9/C-10, C-11. The quaternary feature of C-10
comes from the oxygen linkage between C-5 and C-10 supported by an HMBC correlation of H-5 with
C-10. Therefore, the tricyclic structure of 3 has been established as depicted in Figure 4.
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Table 3. 1H and 13C NMR Spectroscopic data [500 and 125 MHz, CDCl3] of compounds 3, 4 and 5.
No.
3 4 5
δC, Mult. δH (J in Hz) δC, Mult. δH (J in Hz) δC, Mult. δH (J in Hz)
1 39.7 CH 2.64, ddd(4.2, 7.1, 7.1) 35.4 CH 2.90, m 45.7, CH 2.70, m
2 49.7, CH2
2.44, m
.46, m 49.9, CH2
2.53 m
2.53, m 32.3, CH2
3.12, dd (6.6, 14.2)
3.22, dd (8.5, 14.2)
3 215.4, C - 215.3, C - 166.6, C -
4 41.9, CH 2.89, dd(6.6, 6.6, 10.6) 41.7, CH 2.90, m 116.7, C -
5 60.8, CH 3.31, d (10.4) 60.9, CH 3.31, d (10.3) 122.0, CH 7.44, s
6 203.5, C - 205.8, C - 150.6, C -
7 55.9, CH2 2.68, m 55.9, CH2 2.69, m 177.1, CH 9.54, s
8 74.3, C - 74.3, C - 204.3, C -
9 45.6, CH2
b: 1.92, m
a: 2.34, d (15.1) 45.6, CH2
b: 1.90, dd (2.6, 15.4)
a: 2.32, d (15.1) 46.5, CH2
2.63, dd (7.3, 17.7)
2.99, dd (6.7, 17.7)
90.5, C - 90.3, C - 7 .6, CH 5.27, m
15 .9, CH 6.76, s 156.0, CH 6.79, s 14 .7, CH 7. 1, m







b: 2.49, m 23.1, CH2
2.16, m
2.25, m
14 31.7, CH2 1.89, m 31.5, CH2 2.00, m 30.1, CH2
1.64, m
1.72, m
15 149.4, CH - 149.3, C - 144.8, C -
16 109.7, CH2
4.68, br s;
4.70, br s 114.7, CH2
5.00, s;
5.20, dd (0.9, 0.9) 113.6, CH2
4.64, br s
4.73, dd (1.6, 1.6)
7 20. , CH3 1.69, s 47.6, CH2 4.03, m 18.0, CH3 1.68, s
18 17.2, CH3 1.04, d (6.6) 17.3, CH3 1.04, d (6 6 162.9,C -
19 30.1, CH3 1.37, s 30.1, CH3 1.37, s 30.5, CH3 2.21, s
20 170.6, C - 171.6, C - 172.9, C -
OMe - - - - 51.8, CH3 3.86, s
Compound 4 was obtained as an oil whose EIMS spectrum showed peaks at m/z 396/398 [M]+,
which correspond to the formula C20H25ClO6 (HREIMS) (m/z 396.1324 [M]+, calcd. for C20H25O635Cl,
396.1340). Considering the HSQC correlations, signals observed in the 13C NMR spectrum indicate
seven quaternary carbons, four methines, seven methylenes and two methyls. Absorptions for a
hydroxyl group at 3420 cm−1 and carbonyl groups at 1727, 1690 and 1647 cm−1 were observed in their
IR spectrum.
1H and 13C NMR data (Table 3) resemble those of 3. The molecular formula of 4 showed that
one proton of 3 is substituted by a chlorine atom in 4. Its corresponding data from both 1H and 13C
NMR reveal that the substitution is situated on the isopropenyl appendage, where the methyl group of
3 changed to chloromethylene in 4. This substitution was confirmed by the fragment (m/z 321.1335
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[M − C3H4Cl]+, calcd. for C17H21O6, 321.1338) observed in HREIMS. The planar structure of 4 was
confirmed as the 17-chloro derivative of compound 3 by COSY, HSQC and HMBC experiments.
NOESY experiments, studies of coupling constants and molecular mechanics calculations suggest
that 3 and 4 have the same relative stereochemistry (Figure 1). In both compounds, NOEs were
observed for H-5 with H-9a and H-11 and for H3-19 with H-9a and H-9b, defining a relative
configuration for C-5 and C-10 and establishing H3-19 on C-8 in a pseudo-equatorial disposition
and therefore coplanar to H-5. Also, the large coupling constants of H-5 (J = 10.4 Hz) in 3 and H-5
(J = 10.3 Hz) in 4 indicate that H-5 and H-4 are trans-diaxial, as the observed NOE between H-5 and
H3-18 corroborates. Finally, the NOE observed between H-11 and H-1 places the isopropenyl group on
the opposite side to the Me-18. Therefore, the overall relative configuration for 3 and 4 should be 1R*,
4R*, 5S*, 8R* and 10S*.
Compound 5 was obtained as an oil with an EIMS spectrum peak at m/z 388 [M]+, which
corresponds to the molecular formula C21H24O7 (HREIMS) (m/z 388.1524 [M]+, calcd. for C21H24O7,
388.1522). These data are in agreement with the 13C NMR spectrum, which displayed correlations in
the HSQC spectrum indicating eight quaternary carbons, five methines, five methylenes and three
methyls (Table 3). Absorptions for carbonyl groups at 1655, 1650 and 1638 cm−1 were noted in the
IR spectrum.
In addition to the 1H and 13C NMR data registered for an isopropenyl group, a furan ring and a
α,β-unsaturated-γ-lactone, other notable key signals were detected for the following functional groups:
aldehyde [δH-7 9.54 (1H, s), δC-7 177.1]; methyl ketone [δH-19 2.21 (3H, s), δC-8 204.3] and methyl ester
[δH-21 3.86 (3H, s), δC-18 162.9]. The 21 carbon atoms given by the molecular formula suggested that
the isoprenic methyl group C-18 of a regular furanocembranolide is oxidized to a methyl ester and
that the methyl-ketone and the aldehyde might come from the oxidative cleavage of the C-7–C-8 bond.
According to the connectivity information from experiments COSY, HSQC and HMBC, compound 5
should be a seco-furanocembranolide.
1H-1H-COSY experiments established two spin systems: H2-2–H2-13 (fragment I) and H2-9–H-10
(fragment II) (Figure 5). The HMBC correlations of H2-16/C-1, C-17 and H3-17/C-16, C-15,
C-1 locate the isopropenyl group at C-1 of fragment I and also those of H-5/C-3, C-4, C-6 and
H2-2 with C-3 connected fragment I at the furan ring. The HMBC correlations of H2-13/C-11,
C-12, C-20 and H-11/C-10 and H2-9/C-11 showed that fragments I and II are linked through
an α,β-unsaturated-γ-lactone. HMBC correlations of H3-19/C-8, C-9 allowed us to place the
methyl-ketone. Finally, the aldehyde must be located at C-6, in good agreement with the chemical
shift observed for the aldehyde group of seco-bipinnatin J (δH-7 9.52 (1H, s), δC-7 177.5), the only
seco-derivative [9] isolated from Pseudopterogorgia, which showed the same scission pattern.
Compound 5 is the first seco-furanocembranolide isolated from genus Leptogorgia.Z-deoxypukalide [1],
also isolated in this work, can be considered a biogenetic precursor of 5 by oxidative cleavage of the
corresponding ∆7,8. Since Z-deoxypukalide belongs to the α-cembranolide series, we assign the same
relative configurations 1R*, 10S* to 5.
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It should be expected that compounds 1–5 belong to the same enantiomeric series asZ-deoxypukalide,
(6) whose absolute configuration we have previously determined using an NMR-based method using
Pirkle’s reagent [1].
Activation of Pancreatic Beta-Cell Proliferation
Several strategies have been proposed to recover functional beta-cell mass loss in diabetes mellitus
onset; one of them is to activate beta-cell proliferation [3]. In previous work, we showed that
furanocembranolides such as epoxypukalide, pukalide, Z-deoxypukalide and leptolide augment
beta-cell proliferation [4–6]. In order to acquire detailed knowledge of the proliferation effect induced
by furanocembranolides, compounds 1, 2 and rubifolide (7) were used to treat synchronized INS-1
cells and proliferation was then measured. INS-1 cells were preincubated with 0.1 µM of each product
and proliferation was measured by BrdU incorporation (Table 4), showing a 2–3-fold increase in
proliferation. Although it is difficult to reach a conclusion regarding the functional groups that could
modulate this proliferation activity, these results also support chloro-furanocembranolides being
potential activators of pancreatic beta-cell proliferation.
Furthermore, synchronized INS-1 cells were treated with the nor-cembranolide, scabrolide D (8),
(Table 4), showing a 2.8 ± 0.69-fold change above untreated cells (1.0). We therefore consider it
of interest in searching for compounds of the furanocembranolide and nor-1,4-diketocembranolide
families, in order to develop a new class of antidiabetic agents.
Table 4. Beta-cell proliferation measurement after treating INS-1 beta-cells with each compound.
Compound (0.1 µM) Proliferation Ratio a
1 2.5 ± 0.65
2 2.0 ± 0.61
Rubifolide (7) 3.3 ± 0.80 b
Scabrolide D (8) 2.8 ± 0.69 b
a Fold change above untreated cells (1.0). A threshold over 1.5-fold was considered to increase proliferation.
b p < 0.05 versus control.
3. Experimental Section
3.1. General Experimental Procedures
Optical rotations were measured on a Perkin-Elmer model 343 Plus polarimeter (Perkin-Elmer,
Rodgau, Germany) using a Na lamp at 20 ◦C. IR spectra were recorded on a Perkin-Elmer 1650/FTIR
spectrometer (Perkin-Elmer, Rodgau, Germany). 1H NMR and 13C NMR, HSQC, HMBC and COSY
spectra were measured employing a Bruker AMX 500 instrument (Bruker, Karlsruhe, Germany)
operating at 500 MHz for 1H NMR and at 125 MHz for 13C NMR. All 13C and 1H NMR spectra
were internally referenced to the residual solvent signal (CDCl3: δC 77.0 ppm, δH 7.25 ppm).
Two-dimensional NMR spectra were obtained using the standard Bruker software (TOpSpin 2.1,
Bruker, Karlsruhe, Germany). The EIMS data were obtained on a Waters Vg-Micromass spectrometer
(Waters, Manchester, UK) model Zab 2F. HPLC separations were performed on an Agilent 1200
Series Quaternary LC system (Agilent Technologies, Waldbronn, Germany) apparatus equipped
with a UV detector (DAD G1315D, Agilent Technologies, Waldbronn, Germany) and an Ascentis®
C18 semi-preparative column (5 µm, 25 cm × 21.2 mm, Supelco, Bellefonte, PA, USA) eluted with
CH3CN-H2O mixtures. Size-exclusion chromatography used Sephadex LH-20 as stationary phase and
hexane-MeOH-CH2Cl2 (3:1:1) as solvent system. The spray reagent used to develop TLC plates was
H2SO4-H2O-AcOH (1:4:20).
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3.2. Collection, Extraction and Isolation
Leptogorgia sp. was collected by SCUBA diving off Aleta (Panama) at −10 m. A voucher specimen
has been deposited at the Smithsonian Tropical Research Institute (Panama City, Panama) with code
200708. Specimens of Leptogorgia sp. (458.3 g) were extracted with acetone at room temperature and
were concentrated to give a dark gum (10.1 g). C-18 reversed-phase flash chromatography of the crude
extract gave fractions 4 (290.4 mg; 2:3 H2O/MeOH) and 5 (1119.1 mg; 1:4 H2O/MeOH) containing
cembranolides, as indicated by their 1H NMR spectra. Fraction 4 was further chromatographed by
molecular exclusion LH-20 to give two sub-fractions of interest, 41 (39.4 mg) and 45 (18.6 mg). C-18
reversed-phase HPLC of 41 using a gradient from H2O-CH3CN (7:3) to CH3CN (100%) afforded
compound 1 (1.3 mg, tR 61 min) and scabrolide D (8) (6.5 mg, tR 64 min). From sub-fraction 45,
compounds 2 (5.4 mg; tR 101.5 min) and 4 (0.5 mg; tR 83 min) were separated after C-18 reversed-phase
HPLC using a gradient from H2O-CH3CN (7:3) to CH3CN (100%). Fraction 5 was chromatographed
by molecular exclusion LH-20 to give five sub-fractions of interest: 51 (87.6 m), 52 (89.5 mg),
53 (82.9 mg), 54 (59.1 mg) and 55 (50.3 mg). All these fractions were chromatographed separately
by C-18 reversed-phase HPLC using a gradient from H2O-CH3CN (7:3) to CH3CN (100%), to afford
compounds 3 (1.6 mg; tR 83.1 min), 5 (2.1 mg; tR 52.3 min), Z-deoxypukalide (6) (5.7 mg; tR 111.2 min),
rubifolide (7) (6.0 mg; tR 74 min) and epoxylophodione (9) (0.4 mg; tR 82.3 min).
Compound 1: Colourless oil; [α]20D −20.7 (c 0.03, CH2Cl2); IR (film) νmax 3476, 2932, 1776, 1676 cm−1;
1H (500 MHz, CDCl3) δ 1.35 (3H, s, H-19), 1.42 (1H, m, H-14a), 1.45 (1H, m, H-13a), 1.51 (1H, m, H-9),
1.87 (1H, dd, J = 5.2, 15.0 Hz, H-9), 2.04 (1H, m, H-14b), 2.44 (1H, dd, J = 11.5, 14.7 Hz, H-13b), 3.15
(2H, m, H-2), 3.39 (1H, m, H-1), 3.73 (1H, s, H-11), 4.18 (2H, br s, H-17), 4.85 (1H, dd, J = 5.2, 11.3 Hz,
H-10), 5.29 (1H, s, H-7), 5.37 (1H, s, H-16a), 5.47 (1H, s, H-16b), 6.70 (1H, s, H-5), 9.89 (1H, s, H-18); 13C
NMR (125 MHz CDCl3) δ 22.4 (CH3, C-19), 22.5 (CH2, C-13), 30.4 (CH2, C-14), 32.9 (CH2, C-2), 37.6
(CH, C-1), 40.5 (CH2, C-9), 46.6 (CH2, C-17), 60.6 (C, C-12), 62.9 (CH, C-11), 74.0 (CH, C-7), 74.3 (C,
C-8), 74.3 (CH, C-10), 106.5 (CH, C-5), 118.0 (CH2, C-16), 123.4 (C, C-4), 144.2 (C, C-15), 156.0 (C, C-6),
161.3 (C, C-3), 172.0 (C, C-20), 184.7 (CH, C-18); EIMS m/z 409/411 [M − 1]+, 395/397 [M − CH3]+,
393/395 [M − OH]+, 355 [M − C3H4Cl]+; HREIMS m/z [M − 1]+ 409.1041 (calcd. for C20H2235ClO7
409.1054), 411.1027 (calcd. for C20H2237ClO7, 411.1025), 395.0887 (calcd. for C19H2035ClO7, 395.0898),
395.1069 (calcd. for C20H2237ClO6, 395.1075).
Compound 2: Colourless oil; [α]20D −11.0 (c 0.10, CH2Cl2); IR (film) νmax 3558, 2935, 1747, 1674 cm−1;
1H (500 MHz, CDCl3) δ 1.41 (3H, s, H-19), 1.60 (1H, ddd, J = 2.8, 2.8, 15.1 Hz, H-14a), 1.89 (1H, dd,
J = 11.7, 14.8 Hz, H-9b), 2.02 (1H, m, H-14b), 2.14 (1H, m, H-13a), 2.35 (1H, ddd, J = 2.8, 11.9, 15.1 Hz,
H-13b), 2.46 (1H, dddd, J = 2.2, 2.5, 9.5, 11.7 Hz, H-1), 2.59 (1H, dd, J = 4.1, 14.8 Hz, H-9a), 2.97 (1H, dd,
J = 2.5, 14.8 Hz, H-2a), 3.19 (1H, dd, J = 11.9, 15.1 Hz, H-2b), 4.12 (2H, br s, H-17), 4.59 (1H, s, H-7), 4.97
(1H, m, H-10), 5.19 (1H, s, H-16), 5.36 (1H, s, H-16), 5.86 (1H, s, H-11), 6.80 (1H, s, H-5), 9.97 (1H, s,
H-18); 13C NMR (125 MHz, CDCl3) δ 19.6 (CH3, C-19), 21.7 (CH2, C-13), 30.2 (CH2, C-14), 32.7 (CH2,
C-2), 39.7 (CH, C-1), 43.0 (CH2, C-9), 47.2 (CH2, C-17), 73.6 (C, C-8), 75.6 (CH, C-7), 78.4 (CH, C-10),
106.5 (CH, C-5), 117.0 (CH2, C-16), 122.7 (C, C-4), 136.2 (C, C-12), 146.9 (C, C-15), 148.6 (CH, C-11), 154.3
(C, C-6), 162.1 (C, C-3), 173.5 (C, C-20), 184.3 (CH, C-18); EIMS m/z 394/396 [M]+, 377/379 [M − OH]+;
HREIMS m/z [M]+ 394.1181 (calcd. for C20H23O635Cl, 394.1183), 396.1162 (calcd. for C20H23O637Cl,
396.1154), 377.1146 (calcd. for C20H22O535Cl, 377.1156), 379.1133 (calcd. for C20H22O537Cl, 379.1126).
Compound 3: Colourless oil; [α]20D +10.0 (c 0.16, CH2Cl2); IR (film) νmax 3475, 2933, 1751, 1721, 1701 cm
−1;
1H (500 MHz, CDCl3) δ 1.04 (3H, d, J = 6.6 Hz, H-18), 1.37 (3H, s, H-19), 1.69 (3H, s, C-17), 1.89 (2H, m,
H-14), 1.92 (1H, m, H-9b), 2.27 (2H, ddd, J = 5.4, 9.3, 14.3 Hz, H-13a), 2.34 (1H, d, J = 15.1 Hz, H-9a),
2.44 (1H, m, H-2a), 2.46 (1H, m, H-2b), 2.50 (1H, m, H-13b), 2.64 (1H, ddd, J = 4.2, 7.1, 7.1 Hz, H-1),
2.68 (2H, m, H-7), 2.89 (1H, ddd, J = 6.6, 6.6, 10.6 Hz, H-4), 3.31 (1H, d, J = 10.4 Hz, H-5), 4.68 (1H,
br s, H-16a), 4.70 (1H, br s, H-16b), 6.76 (1H, s, H-11); 13C NMR (125 MHz, CDCl3) δ 17.2 (CH3, C-18),
20.9 (CH3, C-17), 24.0 (CH2, C-13), 30.1 (CH3, C-19), 31.7 (CH2, C-14), 39.7 (CH, C-1), 41.9 (CH, C-4),
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45.6 (CH2, C-9), 49.7 (CH2, C-2), 55.9 (CH2, C-7), 60.8 (CH, C-5), 74.3 (C, C-8), 90.5 (C, C-10), 109.7
(CH2, C-16), 131.4 (C, C-12), 149.4 (C, C-15), 155.9 (CH, C-11), 170.5 (C, C-20), 203.5 (C, C-6), 215.4
(C, C-3); EIMS m/z 362 [M]+, 347 [M − CH3]+, 345 [M − OH]+; HREIMS m/z [M]+ 362.1737 (calcd.
for C20H26O6, 362.1729), [M − CH3]+ 347.1509 (calcd. for C19H23O6, 347.1495), 345.1708 (calcd. for
C20H25O5, 345.1702).
Compound 4: Colourless oil; [α]20D +66.0 (c 0.05, CH2Cl2); IR (film) νmax 3420, 2956, 1727, 1690, 1647 cm
−1;
1H (500 MHz, CDCl3) δ 1.04 (3H, d, J = 6.6 Hz, H-18), 1.37 (3H, s, H-19), 1.90 (1H, dd, J = 2.6, 15.4 Hz
H-9b), 2.00 (2H, m, H-14), 2.28 (1H, m, H-13a), 2.32 (1H, d, J = 15.1 Hz, H-9b), 2.49 (1H, m, H-13b), 2.53
(2H, m, H-2), 2.69 (2H, m, H-7), 2.90 (1H, m, H-1), 2.90 (1H, m, H-4), 3.31 (1H, d, J = 10.3 Hz, H-5), 4.03
(2H, m, H-17), 5.00 (1H, s, H-16b), 5.20 (1H, dd, J = 0.9, 0.9 Hz, H-16a), 6.79 (1H, s, H-11); 13C NMR
(125 MHz, CDCl3) δ 17.3 (CH3, C-18), 22.8 (CH2, C-13), 30.1 (CH3, C-19), 31.5 (CH2, C-14), 35.4 (CH,
C-1), 41.7 (CH, C-4), 45.6 (CH2, C-9), 47.6 (CH2, C-17), 49.9 (CH2, C-2), 55.9 (CH2, C-7), 60.9 (CH, C-5),
74.3 (C, C-8), 90.3 (C, C-10), 114.7 (CH2, C-16), 131.1 (C, C-12), 149.3 (C, C-15), 156.0 (CH, C-11), 171.6
(C, C-20), 205.8 (C, C-6), 215.3 (C, C-3); EIMS m/z 396/398 [M]+, 378/380 [M − H2O]+, 361 [M − Cl]+,
321 [M − C3H4Cl]+; HREIMS m/z [M]+ 396.1324 (calcd. for C20H25O635Cl, 396.1340), 398.1315 (calcd.
for C20H25O637Cl, 398.1310), 361.1642 (calcd. for C20H25O6, 361.1651), 321.1335 (calcd. for C17H21O6,
321.1338).
Compound 5: Colourless oil; [α]20D −2.11 (c 0.21, CH2Cl2); IR (film) νmax 2100, 1655, 1650, 1638 cm−1;
1H (500 MHz, CDCl3) δ 1.64 (1H, m, H-14), 1.68 (3H, s, H-17), 1.72 (1H, m, H-14), 2.16 (1H, m, H-13a),
2.21 (3H, s, H-19), 2.25 (1H, m, H-13b), 2.63 (1H, dd, J = 7.3, 17.7 Hz, H-9a), 2.70 (1H, m, H-1), 2.99
(1H, dd, J = 6.7, 17.7 Hz, H-9b), 3.12 (1H, dd, J = 6.6, 14.2 Hz, H-2), 3.22 (1H, dd, J = 8.5, 14.2 Hz, H-2),
3.86 (3H, s, H-21), 4.64 (1H, br s, H-16a), 4.73 (1H, dd, J = 1.6, 1.6 Hz, H-16b), 5.27 (1H, m, H-10), 7.11
(1H, m, H-11), 7.44 (1H, s, H-5), 9.54 (1H, s, H-7); 13C NMR (125 MHz, CDCl3) δ 18.0 (CH3, C-17),
23.1 (CH2, C-13), 30.1 (CH2, C-14), 30.5 (CH3, C-19), 32.3 (CH2, C-2), 45.7 (CH, C-1), 46.5 (CH2, C-9),
51.8 (CH3, C-21), 76.6 (CH, C-10), 113.6 (CH2, C-16), 116.7 (C, C-4), 122.0 (CH, C-5), 134.3 (C, C-12),
144.8 (C, C-15), 147.7 (CH, C-11), 150.6 (C, C-6), 162.9 (C, C-18), 166.6 (C, C-3), 172.9 (C, C-20), 177.1
(CH, C-7), 204.3 (C, C-8); EIMS m/z 388 [M]+, 357 [M−OCH3]+; ESMS m/z [M]+ 388.1524 (calcd. for
C21H24O7, 388.1522), 357.1341 (calcd. for C20H21O6, 357.1338).
3.3. Activation of Pancreatic Beta-Cell Proliferation
INS-1 cells (insulinoma rat cells) were seeded at a density of 20,000 cells per well in 96-well plates.
Compounds 1, 2, rubifolide (7) and scabrolide (8) were assayed at a final concentration of 0.1 µM in
culture medium supplemented with 5.5 mM glucose. Proliferation was measured after 24 h using
the BrdU kit (Roche, Mannheim, Germany), following manufacturer’s instructions. At least three
independent experiments in triplicate were preformed per compound.
Supplementary Materials: The following are available online at www.mdpi.com/1660-3397/16/2/49/s1, Figure
S1: 1H NMR of 1 in CDCl3; Figure S2: 13C NMR spectrum of 1 in CDCl3; Figure S3: 1H NMR of 2 in CDCl3; Figure
S4: 13C NMR spectrum of 2 in CDCl3; Figure S5: 1H NMR of 3 in CDCl3; Figure S6: 13C NMR spectrum of 3 in
CDCl3; Figure S7: 1H NMR of 4 in CDCl3; Figure S8: 13C NMR spectrum of 4 in CDCl3; Figure S9: 1H NMR of 5
in CDCl3; Figure S10: 13C NMR spectrum of 5 in CDCl3.
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